News & Updates
Showing Cardiology articles
Showing
Show Multimedia Only

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo
09 Sep 2025
byAudrey Abella
Data presented at ESMO Gyn 2025 support apixaban as a prophylactic agent for venous thromboembolism (VTE) in women with epithelial ovarian cancer who are undergoing neoadjuvant chemotherapy consisting of carboplatin and paclitaxel.








